News

WTWH Healthcare, a WTWH Media Company, Announces 2025 Aspect Awards Winners

CLEVELAND, March 14, 2025 /PRNewswire/ -- WTWH Healthcare, a WTWH Media company, is proud to announce the winners of the…

9 months ago

FLORIDA SOUTHERN COLLEGE NAMES BRITTANY BEHRENS, MSN, RN, CNE, CHSE, THE MAIDA BADCOCK POU ENDOWED CHAIR IN NURSING SIMULATION

LAKELAND, Fla., March 14, 2025 /PRNewswire/ -- Florida Southern College is excited to announce Brittany Behrens, MSN, RN, CNE, CHSE, as…

9 months ago

BioSurfaces and Morphocell Technologies Announce Collaboration to Explore Therapeutic Applications of Bio-Spun™ Material

ASHLAND, Mass., March 14, 2025 /PRNewswire/ -- BioSurfaces, a leader in advanced nanofiber materials, and Morphocell Technologies, a regenerative medicine…

9 months ago

Biolexis Therapeutics Unlocks a New Frontier in GLP-1 Receptor Activation

CryoEM Confirms a First-in-Class Allosteric Binding Mode, Validating MolecuLern™ AI-Driven Discovery LEHI, Utah, March 14, 2025 /PRNewswire/ -- Biolexis Therapeutics has achieved…

9 months ago

Happy World Sleep Day: Discover the benefits of a good night’s sleep and how Garmin smartwatches can help

Garmin Connect data shows users have been sleeping better over the last year OLATHE, Kan., March 14, 2025 /PRNewswire/ --…

9 months ago

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

UroShield Cited as Effective in Preventing CAUTIs and Blockages, Having a Major Impact on Quality of Life and Reducing Healthcare…

9 months ago

Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments

Raanana, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech…

9 months ago

Hepion Pharmaceuticals Announces Reverse Stock Split

Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025 MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) --…

9 months ago

Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically relevant…

9 months ago

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency (“RF”)…

9 months ago